Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1997 1
1998 2
2000 1
2002 5
2003 2
2004 3
2005 5
2006 6
2007 8
2008 10
2009 8
2010 8
2011 6
2012 4
2013 4
2014 11
2015 11
2016 9
2017 10
2018 10
2019 16
2020 23
2021 27
2022 32
2023 25
2024 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Kim J, Koh DI, Lee M, Park YS, Hong SW, Shin JS, Lee MS, Kim MH, Lee JH, Jeong J, Bae S, Hong JK, Jeong HR, Ryu YS, Kim SM, Choi M, Kim H, Ryu H, Hur SC, Park J, Hur DY, Jin DH. Kim J, et al. Among authors: hong jk. Cell Death Differ. 2023 Dec;30(12):2491-2507. doi: 10.1038/s41418-023-01235-9. Epub 2023 Nov 6. Cell Death Differ. 2023. PMID: 37926711 Free PMC article.
Autoimmune hepatitis triggered by COVID-19.
Hong JK, Chopra S, Kahn JA, Kim B, Khemichian S. Hong JK, et al. Intern Med J. 2021 Jul;51(7):1182-1183. doi: 10.1111/imj.15420. Intern Med J. 2021. PMID: 34278694 Free PMC article. No abstract available.
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.
Koh DI, Lee M, Park YS, Shin JS, Kim J, Ryu YS, Lee JH, Bae S, Lee MS, Hong JK, Jeong HR, Choi M, Hong SW, Kim DK, Lee HK, Kim B, Yoon YS, Jin DH. Koh DI, et al. Among authors: hong jk. Cancer Immunol Res. 2024 Apr 2;12(4):491-507. doi: 10.1158/2326-6066.CIR-23-0817. Cancer Immunol Res. 2024. PMID: 38289363
Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study.
Seok J, Koh YG, Hong JK, Yun SH, Kim DH, Son HS, Choi SY, Yoo KH, Lee YW, Kim BJ. Seok J, et al. Among authors: hong jk. Dermatol Surg. 2024 Jun 1;50(6):527-533. doi: 10.1097/DSS.0000000000004146. Epub 2024 Mar 8. Dermatol Surg. 2024. PMID: 38518110 Clinical Trial.
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Shin SH, Hong JK, Hong SA, Li K, Yoo KH. Shin SH, et al. Among authors: hong jk. Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2. Int J Infect Dis. 2022. PMID: 34740803 Free PMC article. No abstract available.
250 results